As Na­tion­al Par­ty Con­gress con­cludes, Chi­na’s FDA seeks to write wide­ly-an­tic­i­pat­ed drug re­forms in­to law

In a bid to move Chi­nese drug in­dus­try reg­u­la­tions clos­er to the US/Eu­ro­pean mod­el, Chi­na’s FDA yes­ter­day pro­posed sig­nif­i­cant changes to the na­tion’s Drug Ad­min­is­tra­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER